NKTR-214 + Nivo for stage 4 patients gets FDA Breakthrough Therapy Designation
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

NKTR-214 + Nivo for stage 4 patients gets FDA Breakthrough Therapy Designation

› Forums › General Melanoma Community › NKTR-214 + Nivo for stage 4 patients gets FDA Breakthrough Therapy Designation

  • Post
Viewing 3 reply threads
  • Replies
      • August 2, 2019 at 12:59 pm
      ed williams
      Participant
      Here are the two video’s, first from Dr. Weber at ASCO 2018 at the 1:17 min mark and second one from ASCO 2019 featuring Dr. Jason Luke talking about NkTR-214. https://www.onclive.com/inside-oncology/asco-2018-news/asco-2018-dr-weber-highlights-exciting-abstracts-in-melanoma
      • August 2, 2019 at 1:57 pm
      jbronicki
      Participant
      This is fascinating Ed, especially the “Antifreeze” component actually elongating half-life of IL-2, etc

      On a side note, it wasn’t until just recently I’ve started watching the video links (i’ve been used to reading the articles). I have to say, these onclive videos are so FUN (i know that sounds weird) to watch. What would take me days of reading and rereading to even understand, is clearly articulated by these doctors in a different format that is easily ingested. I think I have a much better handle on these treatments from watching these videos. Does Dr. Weber or any of these doctors ever sleep! They do so much, as well as you. THANK YOU for sharing this, the information in this form is so digestable!

      • August 2, 2019 at 5:13 pm
      Bubbles
      Participant
      WOW! That’s great news, Ed! Thanks for sharing! Here’s my take from ASCO 2019 (it’s the first one I reviewed in this link) as well as some perspective on the studies (from 2013 and 2018) leading up to the present – for those of you who are interested: https://chaoticallypreciselifeloveandmelanoma.blogspot.com/2019/06/new-stuff-treatment-options-and-current.html

      Slowly we turn, but turn we do!! c

      • August 3, 2019 at 12:04 am
      jbronicki
      Participant
      Don’t worry Ed, I already have GERD! Dr. Diab though did take a few run throughs. Celeste, just watched videos from Dr. Sondak from Moffitt on intralesionals. Pretty fascinating about how they are trying use the intralesionals not only to treat the injected tumor but also stimulating an overall immune response. I’ve gone down the rabbit hole of watching these videos, have to stop and get dinner now.
Viewing 3 reply threads
  • You must be logged in to reply to this topic.
About the MRF Patient Forum

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

Popular Topics